Pancreatic Cancer: Warnings and Wellness
NFCR Chief Medical Officer Shares His Expertise for Improved Pancreatic Cancer Awareness The National Foundation for Cancer Research (NFCR)’s Dr. Brian Leyland-Jones contributed to the popular online platform Eat This, Not That!’s feature in efforts to spread awareness of one of the most deadly and difficult to detect cancers: 11…...
Thunder God Vine: A Powerful Discovery for Pancreatic Cancer Patients
With a name as powerful as Thunder God Vine comes great responsibility – and National Foundation for Cancer Research (NFCR)-funded researcher Dr. Daniel D. Von Hoff has proven that this medicinal plant is up for the challenge. Dr. Von Hoff is considered one of the nation’s leading authorities on pancreatic cancer. He…...
Coping With Cancer—It’s Different for Everyone
Everyone’s journey with cancer is different, also unique to them is the way in which they cope with the disease. Taking two late celebrities, Alex Trebek and Chadwick Boseman as an example, we can see the differences in how individuals deal with a cancer diagnosis. Pancreatic cancer may only rank…...
Propelling the Fight Against Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDA) is the most common type of pancreatic cancer, making up approximately 95% of the diagnoses. Though pancreatic cancer – in general – is relatively rare, experts expect to see pancreatic cancer rise to become the second leading cause of cancer-related death in the United States by 2030. The general five-year survival…...
Lynparza® Approval Brings New Hope for Pancreatic Cancer Patients
Maintenance therapy previously approved for breast and ovarian cancer patients now shown to reduce the risk of disease progression or death by 47 percent among pancreatic cancer patients. Pancreatic cancer made headlines throughout 2019 after both Jeopardy! host Alex Trebek and U.S. Congressman John Lewis were diagnosed with the devastating…...
Progress in Pancreatic Cancer Research
Pancreatic cancer is a particularly vicious disease. Because the pancreas is nestled deep within the internal organ cavity, identifying the tumor early is a rare occurrence. In fact, over half of the diagnoses occur after the disease has spread to distant parts of the body. As a result, there is…...
New Combination Therapy Improves Pancreatic Cancer Survival
A new combination of two standing drugs and radiation therapy has the potential to revolutionize the treatment and care of pancreatic cancer, one of the most lethal diagnoses an oncologist can face with patients. Using data from studies by NFCR fellow Dr. Rakesh Jain, investigators at Massachusetts General Hospital used…...
November Is Pancreatic Cancer Awareness Month
Even in the company of other vicious diseases, pancreatic cancer is particularly nasty: The one-year relative survival rate is 20% and the five-year rate is 7%. It ranks third in cancer-related deaths in the United States, and it is expected that over 55,000 Americans will be diagnosed this year alone.…...
- 1
- 2
Strategic Media Partner
